New approved drug 2026

Introduction Multiple myeloma is a plasma cell malignancy characterized by uncontrolled monoclonal expansion in the bone marrow, leading to anemia, bone lesions, hypercalcemia, renal dysfunction, and immunosuppression. Over the past decade, targeted immunotherapies have dramatically improved outcomes. Among them, understanding the darzalex faspro mechanism of action is essential for appreciating how modern oncology has shifted …

Read more

Introduction Age-related vision changes affect millions of adults worldwide, and one of the most common conditions is presbyopia. As people age, the natural lens of the eye becomes less flexible, making it harder to focus on nearby objects. Reading small print, checking a smartphone, or working on a laptop may suddenly require reading glasses. Yuvezzi …

Read more

Introduction The treatment landscape for hypertrophic cardiomyopathy (HCM) has dramatically evolved over the past few years. For decades, patients relied primarily on beta-blockers, calcium channel blockers, or invasive procedures like septal myectomy. However, the introduction of cardiac myosin inhibitors revolutionized care. Today, the debate of Aficamten vs Mavacamten is central to discussions among cardiologists, pharmacists, …

Read more

Introduction The approval of novel therapies for rare pediatric diseases represents one of the most critical challenges in modern medicine. Many rare genetic disorders remain underdiagnosed, undertreated, and historically overlooked due to limited commercial incentives and scientific complexity. Against this backdrop, the Zycubo FDA approval stands as a landmark achievement in pediatric rare disease therapy. …

Read more